 |
PDBsum entry 2oa8
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/DNA
|
PDB id
|
|
|
|
2oa8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.1.11.2
- exodeoxyribonuclease Iii.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Degradation of double-stranded DNA. It acts progressively in a 3'- to 5'-direction, releasing nucleoside 5'-phosphates.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
282:10537-10543
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
The crystal structure of TREX1 explains the 3' nucleotide specificity and reveals a polyproline II helix for protein partnering.
|
|
U.de Silva,
S.Choudhury,
S.L.Bailey,
S.Harvey,
F.W.Perrino,
T.Hollis.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The TREX1 enzyme processes DNA ends as the major 3' --> 5' exonuclease activity
in human cells. Mutations in the TREX1 gene are an underlying cause of the
neurological brain disease Aicardi-Goutières syndrome implicating TREX1
dysfunction in an aberrant immune response. TREX1 action during apoptosis likely
prevents autoimmune reaction to DNA that would otherwise persist. To understand
the impact of TREX1 mutations identified in patients with Aicardi-Goutières
syndrome on structure and activity we determined the x-ray crystal structure of
the dimeric mouse TREX1 protein in substrate and product complexes containing
single-stranded DNA and deoxyadenosine monophosphate, respectively. The
structures show the specific interactions between the bound nucleotides and the
residues lining the binding pocket of the 3' terminal nucleotide within the
enzyme active site that account for specificity, and provide the molecular basis
for understanding mutations that lead to disease. Three mutant forms of TREX1
protein identified in patients with Aicardi-Goutières syndrome were prepared
and the measured activities show that these specific mutations reduce enzyme
activity by 4-35,000-fold. The structure also reveals an 8-amino acid
polyproline II helix within the TREX1 enzyme that suggests a mechanism for
interactions of this exonuclease with other protein complexes.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
FIGURE 1. The TREX1 dimer in complex with ssDNA. The TREX1
exonuclease dimerizes about a 2-fold axis perpendicular to the
-strands (monomers shown
in blue and green). This interaction creates an extended
anti-parallel -sheet through the core
of the dimer and places the two active sites on opposite outer
edges. The complex contains ssDNA (shown as sticks) and Ca^2+
(shown as red spheres) bound in both of the active sites.
|
 |
Figure 4.
FIGURE 4. TREX1 structure reveals PPII helix. a, the
non-repetitive proline-rich region within TREX1 forms a PPII.
The PPII helix, made up of residues 54–62, has a tight,
3-sided, left-handed secondary structure. PPII helices often
function as interaction motifs with other proteins containing
SH3, WW, or EVH1 domains. b, location of PPII helices (shown in
red) within the TREX1 dimer. The positioning on opposite outer
edges of the same face of the dimer might play a key role in
TREX1 protein interactions by allowing for simultaneous binding
of multiple interaction domains to the dimer.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2007,
282,
10537-10543)
copyright 2007.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
W.Yang
(2011).
Nucleases: diversity of structure, function and mechanism.
|
| |
Q Rev Biophys,
44,
1.
|
 |
|
|
|
|
 |
Y.Y.Hsiao,
C.C.Yang,
C.L.Lin,
J.L.Lin,
Y.Duh,
and
H.S.Yuan
(2011).
Structural basis for RNA trimming by RNase T in stable RNA 3'-end maturation.
|
| |
Nat Chem Biol,
7,
236-243.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Shimada,
R.Masui,
N.Nakagawa,
Y.Takahata,
K.Kim,
S.Kuramitsu,
and
K.Fukui
(2010).
A novel single-stranded DNA-specific 3'-5' exonuclease, Thermus thermophilus exonuclease I, is involved in several DNA repair pathways.
|
| |
Nucleic Acids Res,
38,
5692-5705.
|
 |
|
|
|
|
 |
F.A.Rey
(2010).
Virology: One protein, many functions.
|
| |
Nature,
468,
773-775.
|
 |
|
|
|
|
 |
N.M.Shaban,
S.Harvey,
F.W.Perrino,
and
T.Hollis
(2010).
The structure of the mammalian RNase H2 complex provides insight into RNA.NA hybrid processing to prevent immune dysfunction.
|
| |
J Biol Chem,
285,
3617-3624.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
X.Qi,
S.Lan,
W.Wang,
L.M.Schelde,
H.Dong,
G.D.Wallat,
H.Ly,
Y.Liang,
and
C.Dong
(2010).
Cap binding and immune evasion revealed by Lassa nucleoprotein structure.
|
| |
Nature,
468,
779-783.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Schwede,
T.Manful,
B.A.Jha,
C.Helbig,
N.Bercovich,
M.Stewart,
and
C.Clayton
(2009).
The role of deadenylation in the degradation of unstable mRNAs in trypanosomes.
|
| |
Nucleic Acids Res,
37,
5511-5528.
|
 |
|
|
|
|
 |
F.W.Perrino,
S.Harvey,
N.M.Shaban,
and
T.Hollis
(2009).
RNaseH2 mutants that cause Aicardi-Goutieres syndrome are active nucleases.
|
| |
J Mol Med,
87,
25-30.
|
 |
|
|
|
|
 |
G.A.Cisneros,
L.Perera,
R.M.Schaaper,
L.C.Pedersen,
R.E.London,
L.G.Pedersen,
and
T.A.Darden
(2009).
Reaction mechanism of the epsilon subunit of E. coli DNA polymerase III: insights into active site metal coordination and catalytically significant residues.
|
| |
J Am Chem Soc,
131,
1550-1556.
|
 |
|
|
|
|
 |
U.de Silva,
F.W.Perrino,
and
T.Hollis
(2009).
DNA binding induces active site conformational change in the human TREX2 3'-exonuclease.
|
| |
Nucleic Acids Res,
37,
2411-2417.
|
 |
|
|
|
|
 |
Y.J.Crow,
and
J.Rehwinkel
(2009).
Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity.
|
| |
Hum Mol Genet,
18,
R130-R136.
|
 |
|
|
|
|
 |
D.A.Lehtinen,
S.Harvey,
M.J.Mulcahy,
T.Hollis,
and
F.W.Perrino
(2008).
The TREX1 double-stranded DNA degradation activity is defective in dominant mutations associated with autoimmune disease.
|
| |
J Biol Chem,
283,
31649-31656.
|
 |
|
|
|
|
 |
D.Kavanagh,
D.Spitzer,
P.H.Kothari,
A.Shaikh,
M.K.Liszewski,
A.Richards,
and
J.P.Atkinson
(2008).
New roles for the major human 3'-5' exonuclease TREX1 in human disease.
|
| |
Cell Cycle,
7,
1718-1725.
|
 |
|
|
|
|
 |
F.W.Perrino,
U.de Silva,
S.Harvey,
E.E.Pryor,
D.W.Cole,
and
T.Hollis
(2008).
Cooperative DNA binding and communication across the dimer interface in the TREX2 3' --> 5'-exonuclease.
|
| |
J Biol Chem,
283,
21441-21452.
|
 |
|
|
|
|
 |
M.Brucet,
J.Querol-Audí,
K.Bertlik,
J.Lloberas,
I.Fita,
and
A.Celada
(2008).
Structural and biochemical studies of TREX1 inhibition by metals. Identification of a new active histidine conserved in DEDDh exonucleases.
|
| |
Protein Sci,
17,
2059-2069.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.Rice,
T.Patrick,
R.Parmar,
C.F.Taylor,
A.Aeby,
J.Aicardi,
R.Artuch,
S.A.Montalto,
C.A.Bacino,
B.Barroso,
P.Baxter,
W.S.Benko,
C.Bergmann,
E.Bertini,
R.Biancheri,
E.M.Blair,
N.Blau,
D.T.Bonthron,
T.Briggs,
L.A.Brueton,
H.G.Brunner,
C.J.Burke,
I.M.Carr,
D.R.Carvalho,
K.E.Chandler,
H.J.Christen,
P.C.Corry,
F.M.Cowan,
H.Cox,
S.D'Arrigo,
J.Dean,
C.De Laet,
C.De Praeter,
C.Dery,
C.D.Ferrie,
K.Flintoff,
S.G.Frints,
A.Garcia-Cazorla,
B.Gener,
C.Goizet,
F.Goutieres,
A.J.Green,
A.Guet,
B.C.Hamel,
B.E.Hayward,
A.Heiberg,
R.C.Hennekam,
M.Husson,
A.P.Jackson,
R.Jayatunga,
Y.H.Jiang,
S.G.Kant,
A.Kao,
M.D.King,
H.M.Kingston,
J.Klepper,
M.S.van der Knaap,
A.J.Kornberg,
D.Kotzot,
W.Kratzer,
D.Lacombe,
L.Lagae,
P.G.Landrieu,
G.Lanzi,
A.Leitch,
M.J.Lim,
J.H.Livingston,
C.M.Lourenco,
E.G.Lyall,
S.A.Lynch,
M.J.Lyons,
D.Marom,
J.P.McClure,
R.McWilliam,
S.B.Melancon,
L.D.Mewasingh,
M.L.Moutard,
K.K.Nischal,
J.R.Ostergaard,
J.Prendiville,
M.Rasmussen,
R.C.Rogers,
D.Roland,
E.M.Rosser,
K.Rostasy,
A.Roubertie,
A.Sanchis,
R.Schiffmann,
S.Scholl-Burgi,
S.Seal,
S.A.Shalev,
C.S.Corcoles,
G.P.Sinha,
D.Soler,
R.Spiegel,
J.B.Stephenson,
U.Tacke,
T.Y.Tan,
M.Till,
and
J.L.Tolmie
(2007).
Clinical and molecular phenotype of Aicardi-Goutieres syndrome.
|
| |
Am J Hum Genet,
81,
713-725.
|
 |
|
|
|
|
 |
M.A.Lee-Kirsch,
M.Gong,
D.Chowdhury,
L.Senenko,
K.Engel,
Y.A.Lee,
U.de Silva,
S.L.Bailey,
T.Witte,
T.J.Vyse,
J.Kere,
C.Pfeiffer,
S.Harvey,
A.Wong,
S.Koskenmies,
O.Hummel,
K.Rohde,
R.E.Schmidt,
A.F.Dominiczak,
M.Gahr,
T.Hollis,
F.W.Perrino,
J.Lieberman,
and
N.Hübner
(2007).
Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus.
|
| |
Nat Genet,
39,
1065-1067.
|
 |
|
|
|
|
 |
Y.G.Yang,
T.Lindahl,
and
D.E.Barnes
(2007).
Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease.
|
| |
Cell,
131,
873-886.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |